Untitled

HealthTrust presents…“Don’t Go Breaking My Heart: Cardiovascular Effects of SGLT-2 Inhibitors & GLP-1 Receptor Agonists”

Download a copy of this content.

Please Note: Continuing education credit is only available to those attending the session live. CE credit is not available when accessing the program on demand.

Individuals with diabetes are at increased risk of developing atherosclerotic cardiovascular disease (ASCVD) due to the presence of cardiac comorbidities, as well as the independent risk factor of diabetes itself. In response to this, there has been emerging data and clinical practice guideline recommendations on the use of sodium-glucose cotransporter-2 (SGLT2) inhibitors and glucagon-like peptide 1 (GLP-1) receptor agonists for patients with high-risk or established ASCVD. Clinical trials have demonstrated cardiovascular benefit with these agents in individuals with diabetes and ASCVD, or indicators of high ASCVD risk. The purpose of this presentation is to evaluate these key clinical trials and discuss how their findings impact clinical pharmacy practice.

Learning Objectives  |  At the end of this session, participants should be able to:

1.  Recall current guideline-directed medical therapy, common cardiovascular risk factors and challenges faced in the treatment of patients with diabetes
2. Identify cardiac effect and clinical outcomes of agents within the sodium-glucose cotransporter-2 (SGLT2) inhibitor and glucagon-like peptide 1 (GLP-1) receptor agonist drug classes when used in the treatment of diabetes
3. Define the role of the pharmacist in promoting positive cardiovascular outcomes in patients with diabetes

Presenter:

Sona Goswami, PharmD  |  PGY-1 Pharmacy Resident  |  Robert Wood Johnson University Hospital

Target Audience:  Pharmacists & Nurses

Continuing Education Information: 1.0 contact hours approved for Nurses and Pharmacists. Belmont University College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The ACPE Universal Activity Number for this activity is 0863-9999-21-092-L01-P. The activity is approved for 1 hour of continuing education credit to nurses and pharmacists who attend the webinar and complete the online evaluation. Pfiedler Education is a division of AORN, provider approved by the California Board of Registered Nursing, Provider Number CEP13019, for 1 contact hour. 1.0 contact hours approved for Nurses.

Note about CE credit: If you plan to obtain credit for a live session, stay until the end of the presentation to receive the verification code you will need to obtain the continuing education credit. CE credit is individual. No group credit is available. Each person must register for a webinar and attend the webinar in its entirety in order to receive an email after the event with instructions on how to apply for continuing education credit. Attendees should not share the code or forward the email to others who did not actually attend the program. If they are not able to be verified on our webinar provider reports and registration list they will not receive credit. If you are joining only by phone, you will not be eligible for credit. You must also log in and join the visual portion of the webinar to be part of our CE provider-required reporting.